News & Events
- Showing 9–16 of 18 items
Trade Show information
ZeptoMetrix® to Release Inactivated Pneumonia Panels for Molecular Diagnostic QC.
RSV, Powassan, Measles, and Mumps
ZeptoMetrix® to Release Additional IVD/CE Marked Molecular Diagnostic Quality Controls.
ZeptoMetrix® to Release Additional P. jirovecii Molecular Control.
Two Group B Streptococcus molecular quality controls added to growing ZeptoMetrix IVD/CE offerings.
Blood Culture Identification Panels are designed to evaluate the performance of nucleic acid tests for determination of the presence of bacterial, and fungal nucleic acids.
ZeptoMetrix® Corporation names Shawn R. Smith it's new President and Chief Executive Officer.